Discontinued — last reported Q4 '20
Investing
Business Sale Proceeds
Year-over-year, this metric declined by 100.0%, from $75.00M to $0.00.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ4 2020
How to read this metric
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
Detailed definition
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Peer comparison
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
Metric ID:
proceeds_from_sale_of_businessHistorical Data
10 periods
| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $11.88M | $11.88M | $11.88M | $11.88M | $75.20M | $75.00M | $0.00 | $0.00 |
| QoQ Change | — | — | — | +0.0% | +0.0% | +0.0% | +533.3% | -0.3% | -100.0% | — |
| YoY Change | — | — | — | — | — | — | +533.3% | +531.6% | -100.0% | -100.0% |
Range$0.00 – $75.20M
Avg YoY Growth+216.2%
Median YoY Growth+215.8%
Current Streak3 quarters decline
Business Sale Proceeds at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's business sale proceeds?
- Roivant Sciences (ROIV) reported business sale proceeds of $0.00 in Q1 2026.
- How has Roivant Sciences's business sale proceeds changed year-over-year?
- Roivant Sciences's business sale proceeds decreased by 100.0% year-over-year, from $75.00M to $0.00.
- What does business sale proceeds mean?
- Cash received from selling off parts of the business.